Cargando…

Method for diagnosing neoplastic lesions by quantitative fluorescence value

Fluorescence visualization devices (FVs) are useful for detecting malignant lesions because of their simple and noninvasive application. However, their quantitative application has been challenging. This study aimed to quantitatively and statistically evaluate the change in fluorescence intensity (F...

Descripción completa

Detalles Bibliográficos
Autores principales: Kosugi, Ayaka, Kasahara, Masataka, Yang, Longqiang, Nakamura-Takahashi, Aki, Shibahara, Takahiko, Mori, Taisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534587/
https://www.ncbi.nlm.nih.gov/pubmed/31127170
http://dx.doi.org/10.1038/s41598-019-44287-z
_version_ 1783421441884028928
author Kosugi, Ayaka
Kasahara, Masataka
Yang, Longqiang
Nakamura-Takahashi, Aki
Shibahara, Takahiko
Mori, Taisuke
author_facet Kosugi, Ayaka
Kasahara, Masataka
Yang, Longqiang
Nakamura-Takahashi, Aki
Shibahara, Takahiko
Mori, Taisuke
author_sort Kosugi, Ayaka
collection PubMed
description Fluorescence visualization devices (FVs) are useful for detecting malignant lesions because of their simple and noninvasive application. However, their quantitative application has been challenging. This study aimed to quantitatively and statistically evaluate the change in fluorescence intensity (FI) during the progression from normal epithelium to squamous cell carcinoma using a reproducible animal tongue carcinogenesis model. To establish this model, rats were treated with 50 ppm 4-Nitroquinoline 1-oxide (4NQO) in their drinking water for 10, 15, and 20 weeks. After 4NQO administration, each rat tongue was evaluated by gross observation, histology, and FI measurements. Fluorescence images were captured by FV, and ImageJ was used to measure FI, which was analyzed quantitatively and statistically. The establishment of a reproducible tumor progression model was confirmed, showing precancerous lesions (low-grade dysplasia [LGD]), early cancers (high-grade dysplasia/carcinoma in situ [HGD/CIS]), and advanced cancers (Cancer). This carcinogenesis model was quantitatively evaluated by FI. The FI of LGD stage was 54.6, which was highest intensity of all groups. Subsequently, the HGD/CIS and Cancer stages showed decreased FI (HGD/CIS: 46.1, Cancer: 49.1) and manifested as dark spots. This result indicates that FI had more variation and a wider range with increasing tumor progression. We demonstrated that FI migration and an uneven distribution are consistent with tumor progression. Since each step of tumor progression occurs reproducibly in this animal model, statistical evaluation was possible. In addition, tumor progression can be monitored by this new FI analysis method in humans.
format Online
Article
Text
id pubmed-6534587
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-65345872019-06-03 Method for diagnosing neoplastic lesions by quantitative fluorescence value Kosugi, Ayaka Kasahara, Masataka Yang, Longqiang Nakamura-Takahashi, Aki Shibahara, Takahiko Mori, Taisuke Sci Rep Article Fluorescence visualization devices (FVs) are useful for detecting malignant lesions because of their simple and noninvasive application. However, their quantitative application has been challenging. This study aimed to quantitatively and statistically evaluate the change in fluorescence intensity (FI) during the progression from normal epithelium to squamous cell carcinoma using a reproducible animal tongue carcinogenesis model. To establish this model, rats were treated with 50 ppm 4-Nitroquinoline 1-oxide (4NQO) in their drinking water for 10, 15, and 20 weeks. After 4NQO administration, each rat tongue was evaluated by gross observation, histology, and FI measurements. Fluorescence images were captured by FV, and ImageJ was used to measure FI, which was analyzed quantitatively and statistically. The establishment of a reproducible tumor progression model was confirmed, showing precancerous lesions (low-grade dysplasia [LGD]), early cancers (high-grade dysplasia/carcinoma in situ [HGD/CIS]), and advanced cancers (Cancer). This carcinogenesis model was quantitatively evaluated by FI. The FI of LGD stage was 54.6, which was highest intensity of all groups. Subsequently, the HGD/CIS and Cancer stages showed decreased FI (HGD/CIS: 46.1, Cancer: 49.1) and manifested as dark spots. This result indicates that FI had more variation and a wider range with increasing tumor progression. We demonstrated that FI migration and an uneven distribution are consistent with tumor progression. Since each step of tumor progression occurs reproducibly in this animal model, statistical evaluation was possible. In addition, tumor progression can be monitored by this new FI analysis method in humans. Nature Publishing Group UK 2019-05-24 /pmc/articles/PMC6534587/ /pubmed/31127170 http://dx.doi.org/10.1038/s41598-019-44287-z Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Kosugi, Ayaka
Kasahara, Masataka
Yang, Longqiang
Nakamura-Takahashi, Aki
Shibahara, Takahiko
Mori, Taisuke
Method for diagnosing neoplastic lesions by quantitative fluorescence value
title Method for diagnosing neoplastic lesions by quantitative fluorescence value
title_full Method for diagnosing neoplastic lesions by quantitative fluorescence value
title_fullStr Method for diagnosing neoplastic lesions by quantitative fluorescence value
title_full_unstemmed Method for diagnosing neoplastic lesions by quantitative fluorescence value
title_short Method for diagnosing neoplastic lesions by quantitative fluorescence value
title_sort method for diagnosing neoplastic lesions by quantitative fluorescence value
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534587/
https://www.ncbi.nlm.nih.gov/pubmed/31127170
http://dx.doi.org/10.1038/s41598-019-44287-z
work_keys_str_mv AT kosugiayaka methodfordiagnosingneoplasticlesionsbyquantitativefluorescencevalue
AT kasaharamasataka methodfordiagnosingneoplasticlesionsbyquantitativefluorescencevalue
AT yanglongqiang methodfordiagnosingneoplasticlesionsbyquantitativefluorescencevalue
AT nakamuratakahashiaki methodfordiagnosingneoplasticlesionsbyquantitativefluorescencevalue
AT shibaharatakahiko methodfordiagnosingneoplasticlesionsbyquantitativefluorescencevalue
AT moritaisuke methodfordiagnosingneoplasticlesionsbyquantitativefluorescencevalue